Hosted on MSN
CBAT: The battery cell business remains challenging in 2025, but a substantial capacity upgrade is looming.
CBAK Energy Technology (NASDAQ:CBAT) released its second-quarter results roughly in line with our forecast, which we had previously adjusted to reflect the planned upgrade to the Dalian production ...
Ultium Cells will furlough 710 of its employees as its Spring Hill, Tenn. plant braces for a temporary pause in production next year. The Spring Hill battery assembly plant, a joint partnership ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in ...
The $644 million facility—set for completion in 2027—will mass-produce 30,000 fuel cell units annually, along with PEM electrolyzers. I n late October, Hyundai Motor Company held a groundbreaking ...
Asahi Kasei, a diversified global company, Nippon Steel, and Nippon Steel Trading have launched a recycling initiative to convert pure titanium scrap generated during the manufacturing of electrolysis ...
This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results